Growth Metrics

Rigel Pharmaceuticals (RIGL) Net Margin Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -3,082.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1,120.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -653.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 7,849.00
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn -675.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -675.00
Dec 31, 2025 35,914.00
Sep 30, 2025 1,771.00
Jun 30, 2025 6,142.00
Mar 31, 2025 4,939.00
Dec 31, 2024 2,284.00
Sep 30, 2024 4,269.00
Jun 30, 2024 2,175.00
Mar 31, 2024 2,400.00
Dec 31, 2023 -67.00
Sep 30, 2023 6,472.00
Jun 30, 2023 2,070.00
Mar 31, 2023 11,208.00
Dec 31, 2022 11,347.00
Sep 30, 2022 1,231.00
Jun 30, 2022 737.00
Mar 31, 2022 -21,275.00
Dec 31, 2021 -647.00
Sep 30, 2021 -2,018.00
Jun 30, 2021 5,709.00
Mar 31, 2021 1,066.00
Dec 31, 2020 742.00
Sep 30, 2020 -2,199.00
Jun 30, 2020 8,830.00
Mar 31, 2020 17,750.00
Dec 31, 2019 -12,022.00
Sep 30, 2019 43,342.00
Jun 30, 2019 123,216.00
Dec 31, 2018 -56,844.00
Sep 30, 2018 147,371.00
Dec 31, 2017 109,663.00
Sep 30, 2017 -136,039.00
Mar 31, 2017 -8,002.00
Dec 31, 2016 -37,105.00
Sep 30, 2016 -55,050.00
Jun 30, 2016 11,089.00
Mar 31, 2016 48,804.00
Jun 30, 2013 2,291.00
Jun 30, 2012 378,726.00
Sep 30, 2011 -48,151.00
Jun 30, 2011 -549,111.00